雅虎香港 搜尋

登入

搜尋結果

  1. www.news.sanofi.us › press-releasesSanofi US Media Room - Dermik Laboratories announces FDA ...

    BRIDGEWATER, N.J., Sept. 19 / PRNewswire-FirstCall / -- Dermik Laboratories, the dermatology business of sanofi-aventis U.S. LLC, announced today the Food and Drug Administration (FDA) has accepted for filing the company's supplemental premarket approval application (s-PMA) for Sculptra (R) (injectable poly-L-lactic acid) for facial cosmetic use.

  2. news.sina.com.cn › sx › 2023/05/17高德美Sculptra：首个获得美国FDA批准用于面颊部除皱适应症的聚 ... 簡

    2023年5月17日 · Sculptra [i] 有助于改善皮肤质量，效果可持续2年 1-2. Sculptra是首个获得FDA批准的"面颊部除皱"适应症的PLLA（注射用聚左旋乳酸）型聚左旋乳酸填充剂 ...

  3. www.bioz.com › result › sculptraSculptra | Sanofi | Bioz

    Journal: World Journal of Otorhinolaryngology - Head and Neck Surgery Article Title: Facial fillers: Relevant anatomy, injection techniques, and complications doi: 10.1002/wjo2.126 Figure Lengend Snippet: Summary of facial fillers. Article Snippet: Poly‐ l ‐lactic acid (PLLA) , Sculptra (Sanofi‐aventis) , Long lasting , Stimulates collagen production, higher viscosity, moderate to severe ...

  4. www.prnewswire.com › news-releases › galderma-receives-fdaGALDERMA RECEIVES FDA APPROVAL FOR SCULPTRA® FOR CHEEK ...

    2023年4月26日 · DALLAS, April 26, 2023 /PRNewswire/ -- Galderma announced today that the U.S. Food and Drug Administration (FDA) has approved Sculptra ® (injectable poly-L-lactic acid (PLLA-SCA)) for the ...

  5. www.sanofi.com › es › chileSanofi Chile: compañía global de salud y ...

    Sobre Sanofi. Somos una compañía farmacéutica de origen francés, presente en Cono Sur (Argentina, Chile, Uruguay y Paraguay) desde hace más de 40 años. Tenemos más de un siglo de historia y experiencia en salud a nivel global: empezamos como una pequeña empresa francesa y luego de fusiones y adquisiciones nos convertimos en un líder ...

  6. www.drugs.com › history › sculptraSculptra (injectable poly-L-lactic acid) FDA Approval Histor ...

    2004年8月3日 · Sculptra FDA Approval History FDA Approved: Yes (First approved August 3, 2004) Brand name: Sculptra Generic name: injectable poly-L-lactic acid Company: Sanofi-aventis U.S. Treatment for: Facial Lipoatrophy; Facial Wrinkles Sculptra (injectable poly-L-lactic acid) is a dermal filler indicated for the restoration and/or correction of the signs of facial fat loss (lipoatrophy) in people with ...

  7. www.accessdata.fda.gov › cdrh_docs › pdf3SUMMARY OF SAFETY AND EFFECTIVENESS DATA

    2. 2. 2 category. Adverse Events reported as "Others" are headache, dry~skin, skin peeling, rash at injection, pimples, improvement ofallergy symptoms, needle marks, sinus pressure, bruising, 6nouth sores, tenderness and twitching of nostril. Page 3 of 20.